Economic impact of rheumatoid arthritis (RA) biotherapies in France.

Milka Maravic

Medicine
Published in
Joint, bone, spine : revue du…
2010
DOI:10.1016/j.jbspin.2010.04.001

Economic impact of rheumatoid arthritis (RA) biotherapies in France.

@article{Maravic2010EconomicIO,
  title={Economic impact of rheumatoid arthritis (RA) biotherapies in France.},
  author={Milka Maravic},
  journal={Joint, bone, spine : revue du rhumatisme},
  year={2010},
  volume={77 4},
  pages={
          319-24
        }
}

Milka Maravic

OBJECTIVE Determining the economic impact of rheumatoid arthritis (RA) biotherapies in France. METHOD The number of patients on RA biotherapy in France was estimated from the French national medical information system program (PMSI) database using the 2007 hospital data. The cost of each biotherapy was calculated on a theoretical basis (French national health authority (HAS) recommendations) and on real-life setting, using 'real-life' setting data. In order to calculate the economic impact of… CONTINUE READING

View on PubMed